Bastide le Confort Medical SA
PAR:BLC

Watchlist Manager
Bastide le Confort Medical SA Logo
Bastide le Confort Medical SA
PAR:BLC
Watchlist
Price: 22 EUR Market Closed
Market Cap: €162.1m

Wall St Price Targets

BLC Price Targets Summary
Bastide le Confort Medical SA

Wall Street analysts forecast BLC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BLC is 31.62 EUR with a low forecast of 31.31 EUR and a high forecast of 32.55 EUR.

Lowest Forecast
Price Target
31.31 EUR
42% Upside
Average Forecast
Price Target
31.62 EUR
44% Upside
Highest Forecast
Price Target
32.55 EUR
48% Upside
Bastide le Confort Medical SA Competitors:
Price Targets
4337
Pia Corp
36% Upside
WRLD
World Acceptance Corp
12% Upside

Revenue
Forecast

11% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

15% / Year
Past Growth
-6% / Year
Estimated Growth
Estimates Accuracy
-30%
Average Miss
15% / Year
Past Growth
-6% / Year
Estimated Growth
Estimates Accuracy
-30%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 6 years is -6%.

Operating Income
Forecast

14% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
14% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 6%.

Pre-Tax Income
Forecast

4% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
4% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 39%.

Net Income
Forecast

-14% / Year
Past Growth
228% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
-14% / Year
Past Growth
228% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -14%. The projected CAGR for the next 3 years is 228%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BLC's stock price target?
Price Target
31.62 EUR

According to Wall Street analysts, the average 1-year price target for BLC is 31.62 EUR with a low forecast of 31.31 EUR and a high forecast of 32.55 EUR.

What is the Revenue forecast for Bastide le Confort Medical SA?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for Bastide le Confort Medical SA?
Projected CAGR
-6%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 6 years is -6%.

What is the Operating Income forecast for Bastide le Confort Medical SA?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 6%.

What is the Pre-Tax Income forecast for Bastide le Confort Medical SA?
Projected CAGR
39%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 39%.

What is the Net Income forecast for Bastide le Confort Medical SA?
Projected CAGR
228%

Over the last 13 years, the compound annual growth rate for Net Income has been -14%. The projected CAGR for the next 3 years is 228%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett